Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Xsensio | 2026 | Series A | $7.0M | Lausanne |
| ATRO Medical | 2026 | Series Unknown | $3.5M | Nijmegen |
| Step Pharma | 2026 | Grant | $2.9M | Paris |
| HeyCharge | 2026 | Grant | $3.0M | Munich |
| DePoly | 2026 | Seed | Undisclosed | Sion |
| CrannMed | 2026 | Grant | $14.8M | Dublin |
| CubaseBio | 2026 | Seed | $4.6M | Stockholm |
| NEOGAP Therapeutics | 2026 | Series Unknown | $9.8M | Stockholm |
| R3 Robotics | 2026 | Series A | $16.5M | Foetz |
| Vexlum | 2026 | Series Unknown | $7.1M | Tampere |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 176 | Xsensio | Series A | $7.0M | Lausanne, Switzerland |
| 177 | ATRO Medical | Series Unknown | $3.5M | Nijmegen, The Netherlands |
| 178 | Step Pharma | Grant | $2.9M | Paris, France |
| 179 | HeyCharge | Grant | $3.0M | Munich, Germany |
| 180 | DePoly | Seed | Undisclosed | Sion, Switzerland |
| 181 | CrannMed | Grant | $14.8M | Dublin, Ireland |
| 182 | CubaseBio | Seed | $4.6M | Stockholm, Sweden |
| 183 | NEOGAP Therapeutics | Series Unknown | $9.8M | Stockholm, Sweden |
| 184 | R3 Robotics | Series A | $16.5M | Foetz, Luxembourg |
| 185 | Vexlum | Series Unknown | $7.1M | Tampere, Finland |
Xsensio develops Lab-on-Skin technology for next-generation wearables that enable real-time biochemical sensing for healthcare applications.
Medical technology company developing a polymer meniscus implant.
Step Pharma is a biotechnology company.
HeyCharge provides charging infrastructure, payment systems, and installation for electric vehicles.
DePoly is a PET-to-raw-material recycling company that converts dirty, post-consumer plastic items into valuable raw materials.
CrannMed is developing resorbable embolic particles and a custom delivery catheter for the treatment of Knee Osteoarthritis.
Cubase Bio is a biotechnology business that focuses on spatial biology tools.
NEOGAP Therapeutics is a Pharmaceutical manufacturing industry.
R3 Robotics is an industrial robotics company that develops AI-powered automated disassembly systems for end-of-life processing.
Vexlum Provider of high-brightness semiconductor laser technology.
Remote patient monitoring (RPM) for patients at risk of diabetic foot disease.
ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases.
Aviwell develops natural biological solutions and computational tools that support animal health and growth in animal nutrition markets.
Orbem provides AI-powered imaging and analytics solutions to deliver non-invasive biological insights.
FineHeart is a medical device company
Oxcia is a biopharmaceutical company that provides therapies and DNA damage response mechanisms to treat cancer and inflammatory diseases.
BIOWEG is a biotechnology company that develops bio-based, biodegradable ingredients to replace fossil-derived polymers and microplastics.
PlusVitech develops effective and safe therapeutic treatments and complementary diagnostic tests for cancer patients.
Melt&Marble is a biotechnology company that creates designer fats and lipids through precision fermentation and microbial engineering.
Lace Lithography develops chip patterning technology, aiming to extend Moore's Law and enable future chip production.
The AlzeCure Foundation is focused on the development of novel diagnostics and therapeutics for PD.
We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
Swisspod is a technology company that develops energy-efficient hyperloop systems that specializes in high speed transportation solutions.
Zadient Technologies is a company engaged in production of synthetic silicon carbide a building block for power semiconductors.
Modvion designs, produces, and installs wind turbine towers constructed from engineered wood.
European Innovation Council has invested in 594 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
European Innovation Council's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Pharmaceutical. The firm invests across 40 different industry categories.
Among tracked funding rounds, Orbem received $64.6M in a Series B round. European Innovation Council's total known invested capital is $4.8B.
European Innovation Council's average investment size is $11.3M across its portfolio of 594 companies.
Recent European Innovation Council portfolio additions include Xsensio, ATRO Medical, Step Pharma, HeyCharge, DePoly. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors